Paget's disease of the breast natural history, complications and prognosis
Paget's disease of the breast Microchapters |
Differentiating Paget's disease of the breast from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Paget's disease of the breast natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Paget's disease of the breast natural history, complications and prognosis |
FDA on Paget's disease of the breast natural history, complications and prognosis |
CDC on Paget's disease of the breast natural history, complications and prognosis |
Paget's disease of the breast natural history, complications and prognosis in the news |
Blogs on Paget's disease of the breast natural history, complications and prognosis |
Directions to Hospitals Treating Paget's disease of the breast |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Prognosis
The prognosis for people with Paget's disease of the breast depends on a variety of factors. Some factors indicate an unfavorable prognosis, among them:[1] [2]
- Presence of palpable breast tumor
- Enlarged lymph nodes
- Histological type of breast cancer
- Patients younger than 60 years
The presence of invasive cancer in the affected breast and the spread of cancer to nearby lymph nodes are associated with reduced survival.
According to NCI’s Surveillance, Epidemiology, and End Results program, the 5-year relative survival for all women in the United States who were diagnosed with Paget's disease of the breast between 1988 and 2001 was 82.6 percent. This compares with a 5-year relative survival of 87.1 percent for women diagnosed with any type of breast cancer. For women with both Paget's disease of the breast and invasive cancer in the same breast, the 5-year relative survival declined with increasing stage of the cancer (stage I, 95.8 percent; stage II, 77.7 percent; stage III, 46.3 percent; stage IV, 14.3 percent).
When there is a palpable breast mass, almost always the carcinoma is invasive and associated with high rates of axillary lymph node metastases. Lymph node involvement is correlated with median survival rates, reaching 75-95% when negative and 20 to 25% when positive. In another study, the mean 10-year survival rate was estimated at 47% in cases with positive lymph nodes and 93% in those with negative lymph nodes. When the disease occurs in males, the prognosis is poor, with an average 5-year survival rate of 20-30%.
Prognosis
- Some factors indicate an unfavorable prognosis, among them:[1]
- The presence of a palpable breast tumor
- Enlarged lymph nodes
- Histological type of breast cancer
- Patients younger than 60 years
- Lymph node involvement is correlated with median survival rates, reaching 75-95% when negative and 20 to 25% when positive.
- In another study, the mean 10-year survival rate was estimated at 47% in cases with positive lymph nodes and 93% in those with negative lymph nodes.
- When the disease occurs in males, the prognosis is poor, with an average 5-year survival rate of 20-30%.
References
- ↑ 1.0 1.1 Lopes Filho, Lauro Lourival; Lopes, Ione Maria Ribeiro Soares; Lopes, Lauro Rodolpho Soares; Enokihara, Milvia M. S. S.; Michalany, Alexandre Osores; Matsunaga, Nobuo (2015). "Mammary and extramammary Paget's disease". Anais Brasileiros de Dermatologia. 90 (2): 225–231. doi:10.1590/abd1806-4841.20153189. ISSN 1806-4841.
- ↑ Paget's disease of the breast. National cancer institute. http://www.cancer.gov/types/breast/paget-breast-fact-sheet